In conclusion, reduced MCC expression sensitizes mouse embryo fibroblast and HCT116 colon cancer cells to SN38/irinotecan-induced cell death, and PARP inhibitor Olaparib augments this effect. This evidence concerns the gene PARP1 and malignant colon neoplasm.